CRD-TMH-001

N/A

Report date: 2025/08/11 17:53:23

Base Information

Drug NameCRD-TMH-001
Drug Alias NameCRD-TMH-001
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionDystrophin gene transference
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCure Rare Disease
China Registration ClassN/A

Develop Information

Active CompaniesCure Rare Disease
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A